Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors

Clinical trial NCT06176989 · RECRUITING

Trial details

NCT number: NCT06176989
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Chondrosarcoma Locally Advanced Chondrosarcoma Metastatic Sinonasal Adenocarcinoma Locally Advanced Sinonasal Adenocarcinoma Metastatic Large-cell Neuroendocrine Carcinoma Locally Advanced Large-cell Neuroendocrine Carcinoma Metastatic Olfactory Neuroblastoma Locally Advanced Olfactory Neuroblastoma Metastatic Sinonasal Undifferentiated Carcinoma Locally Advanced Sinonasal Undifferentiated Carcinoma

Start date: 2024-03-04
Primary completion: 2027-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.